Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD8 cytotoxic T-cell infiltrates and cellular damage in the hypothalamus in human obesity.

Acta neuropathologica communications·2023
Same author

Fatal Post COVID mRNA-Vaccine Associated Cerebral Ischemia.

The Neurohospitalist·2023
Same author

Hominoid SVA-lncRNA AK057321 targets human-specific SVA retrotransposons in SCN8A and CDK5RAP2 to initiate neuronal maturation.

Communications biology·2023
Same author

UBE3A and transsynaptic complex NRXN1-CBLN1-GluD1 in a hypothalamic VMHvl-arcuate feedback circuit regulates aggression.

bioRxiv : the preprint server for biology·2023
Same author

Enhanced recovery after cardiac surgery protocol reduces perioperative opioid use.

JTCVS open·2023
Same author

Symptoms of bowel obstruction following remote total pancreatectomy with auto-islet cell transplantation.

Surgery open science·2022
Same journal

Hearing in Our Sleep-Can We Drown Out Epileptic Spikes and Boost Cognition?

Epilepsy currents·2026
Same journal

Sleep Smarter: Optimal Sleep May Preserve Cognition and Reduce Dementia Risk in Focal Epilepsy.

Epilepsy currents·2026
Same journal

Microglia-Mediated Disinhibition: Taking the Brakes off Epileptic Networks.

Epilepsy currents·2026
Same journal

Brainstem Disinhibition Destabilizes Breathing in Dravet Syndrome, Leading to Sudden Unexpected Death in Epilepsy (SUDEP).

Epilepsy currents·2026
Same journal

Agree to Disagree: Reliability of Seizure Frequency Assessments.

Epilepsy currents·2026
Same journal

Between Epilepsy and Neurodegeneration: The Hidden Architecture of Late-Onset Unexplained Epilepsy.

Epilepsy currents·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

Arrested glutamatergic synapse development in human partial epilepsy.

Matthew P Anderson

    Epilepsy Currents
    |December 16, 2010
    PubMed
    Summary
    This summary is machine-generated.

    Leucine-rich glioma-inactivated 1 (LGI1) protein regulates brain development by controlling glutamatergic synapse maturation. Aberrant LGI1 function contributes to epilepsy and limbic encephalitis, impacting neurological health.

    More Related Videos

    Preparation of Acute Human Hippocampal Slices for Electrophysiological Recordings
    07:31

    Preparation of Acute Human Hippocampal Slices for Electrophysiological Recordings

    Published on: May 7, 2020

    Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
    08:47

    Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

    Published on: November 8, 2018

    Related Experiment Videos

    Last Updated: Jun 6, 2026

    Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
    09:07

    Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

    Published on: August 15, 2017

    Preparation of Acute Human Hippocampal Slices for Electrophysiological Recordings
    07:31

    Preparation of Acute Human Hippocampal Slices for Electrophysiological Recordings

    Published on: May 7, 2020

    Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
    08:47

    Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

    Published on: November 8, 2018

    Area of Science:

    • Neuroscience
    • Molecular Biology
    • Epileptology

    Background:

    • Leucine-rich glioma-inactivated 1 (LGI1) is implicated in human partial epilepsy.
    • LGI1 is a secreted protein involved in brain development.
    • Persistent immaturity of glutamatergic circuitries is a newly identified mechanism of epileptogenesis.

    Purpose of the Study:

    • To elucidate the role of LGI1 in regulating glutamatergic synapse development and its implications in neurological disorders.
    • To investigate the function of LGI1 in the context of brain maturation and synaptic plasticity.
    • To explore the connection between LGI1 autoantibodies and limbic encephalitis.

    Main Methods:

    • Utilized bacterial artificial chromosome transgenic mouse models to study LGI1 function.
    • Investigated the effects of wild-type and truncated LGI1 on synaptic development in the hippocampus.
    • Performed germline gene deletion to assess LGI1's role in synaptic transmission.
    • Analyzed patient samples for autoantibodies against LGI1 in limbic encephalitis.

    Main Results:

    • Excess LGI1 magnifies developmental pruning and synapse maturation, while a dominant-negative form inhibits these processes.
    • LGI1 deficiency leads to increased glutamatergic synaptic transmission without affecting GABAergic synapses or neuronal excitability.
    • LGI1 autoantibodies are present in a subset of patients with limbic encephalitis, an autoimmune disorder associated with memory loss and seizures.

    Conclusions:

    • LGI1 plays a critical role in the downregulation of glutamatergic synapse function during postnatal brain development.
    • Dysregulation of LGI1 contributes to epileptogenesis and is linked to autoimmune neurological diseases like limbic encephalitis.
    • LGI1 represents a potential therapeutic target for epilepsy and related neurological conditions.